These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4913426)

  • 21. Carcinoid syndrome: an unusual cause of diarrhoea.
    King MD; Young DG; Hann IM; Patrick WJ
    Arch Dis Child; 1985 Mar; 60(3):269-71. PubMed ID: 2580492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carcinoid syndrome: An example due to an ileal polyp.
    Orr KB
    Aust N Z J Surg; 1970 Feb; 39(3):268-72. PubMed ID: 4192147
    [No Abstract]   [Full Text] [Related]  

  • 23. The relation between vanilyl mandelic acid and 5-hydroxyindoleacetic acid excretion in a patient with a carcinoid tumour.
    Marshall PB
    J Pharm Pharmacol; 1966 Nov; 18(11):764-5. PubMed ID: 4382061
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current views on carcinoid and the carcinoid syndrome].
    Ryss ES
    Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993
    [No Abstract]   [Full Text] [Related]  

  • 25. Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.
    Kulke MH; O'Dorisio T; Phan A; Bergsland E; Law L; Banks P; Freiman J; Frazier K; Jackson J; Yao JC; Kvols L; Lapuerta P; Zambrowicz B; Fleming D; Sands A
    Endocr Relat Cancer; 2014 Oct; 21(5):705-14. PubMed ID: 25012985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ileal carcinoid tumors. Predominant lesions of the left endocardium].
    Warter J; Batzenschlager A; Schirardin H; Grappe JM; Berthier G; Monath C
    Ann Med Interne (Paris); 1971 Oct; 122(10):967-74. PubMed ID: 5150731
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of the carcinoid syndrome: its relationship to serotonin, bradykinin, and histamine.
    Gardner B; Dollinger M; Silen W; Back N; O'Reilly S
    Surgery; 1967 Jun; 61(6):846-52. PubMed ID: 5298002
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastrointestinal carcinoids and the carcinoid syndrome: clinical characteristics and therapy.
    Crowder BL; Judd ES; Dockerty MB
    CA Cancer J Clin; 1968; 18(4):212-8. PubMed ID: 4992871
    [No Abstract]   [Full Text] [Related]  

  • 29. METASTASISING ISLET-CELL TUMOUR OF THE PANCREAS ASSOCIATED WITH HYPOGLYCAEMIA AND CARCINOID SYNDROME.
    VAN DER VEER JS; CHOUFOER JC; QUERIDO A; VAN DER HEUL RO; HOLLANDER CF; VAN RIJSSEL T
    Lancet; 1964 Jun; 2(7348):1416-9. PubMed ID: 14149167
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant argentaffinoma with carcinoid syndrome and hypoglycaemia.
    Adamson AR; Grahame-Smith DG; Bogomoletz V; Maw DS; Rothnie NG
    Br Med J; 1971 Jul; 3(5766):93-4. PubMed ID: 5314568
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical aspects of indolealkylamine metabolism. Introductory remarks.
    Sjoerdsma A
    Adv Pharmacol (1962); 1968; 6(Pt B):123-5. PubMed ID: 5688650
    [No Abstract]   [Full Text] [Related]  

  • 32. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.
    Kulke MH; Hörsch D; Caplin ME; Anthony LB; Bergsland E; Öberg K; Welin S; Warner RR; Lombard-Bohas C; Kunz PL; Grande E; Valle JW; Fleming D; Lapuerta P; Banks P; Jackson S; Zambrowicz B; Sands AT; Pavel M
    J Clin Oncol; 2017 Jan; 35(1):14-23. PubMed ID: 27918724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The carcinoid syndrome].
    Marcussen H
    Ugeskr Laeger; 1970 Jun; 132(25):1183-7. PubMed ID: 5449339
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinoid syndrome treated with streptozotocin.
    Iweze FI; Owen-Smith M; Polak J
    Proc R Soc Med; 1972 Feb; 65(2):164-5. PubMed ID: 4263805
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection and biochemical exploration of carcinoid tumors].
    Dreux C; Bousquet B; Halter D
    Nouv Presse Med; 1974 Mar; 3(11):671-6. PubMed ID: 4546018
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic acidosis in patients with the carcinoid syndrome: treatment with parachlorophenylalanine.
    Feldman JM
    J Surg Oncol; 1982 Apr; 19(4):219-23. PubMed ID: 6176809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea.
    Dillon JS; Chandrasekharan C
    Future Oncol; 2018 May; 14(12):1155-1164. PubMed ID: 29350062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telotristat ethyl (Xermelo) for carcinoid syndrome diarrhea.
    Med Lett Drugs Ther; 2017 Jul; 59(1525):119-120. PubMed ID: 28699933
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary free cortisol excretion in patients with hyperserotoninaemia from the carcinoid syndrome.
    Feldman JM
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):541-8. PubMed ID: 316372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pressing situation.
    Scialla JJ; Hemnes AR
    Am J Med; 2005 Dec; 118(12):1347-9. PubMed ID: 16378775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.